You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Patent: 7,968,104


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,968,104
Title:Use of neurotoxin therapy for treatment of urologic and related disorders
Abstract: The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.
Inventor(s): Schmidt; Richard A (Arvada, CO)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:12/133,198
Patent Claims:see list of patent claims

Details for Patent 7,968,104

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Sign Up 2017-07-15
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Sign Up 2017-07-15
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 7,968,104

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9903483 ⤷  Sign Up
United States of America 9066943 ⤷  Sign Up
United States of America 8840905 ⤷  Sign Up
United States of America 8062643 ⤷  Sign Up
United States of America 8057807 ⤷  Sign Up
United States of America 7470431 ⤷  Sign Up
United States of America 7455845 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.